Âé¶ą´«Ă˝Ół»­

Back to Top

Our newsroom features all of the latest news, publications and media coverage for the Pediatric Immunotherapy Program. 

 

Woman holds child beside car

Hyundai invests $400,000 in pediatric cancer research at Âé¶ą´«Ă˝Ół»­

“We really rely on people like Hyundai who understand the need and give hope to these kids,” says David Munn, MD.

Six adults and two children, one in a wheelchair, stand in the lobby of a children's hospital. One adult is wearing a doctor's lab coat and is holding a large check.

Hyundai invests $400,000 in pediatric cancer research

“This could positively impact care for children with brain tumors by improving their quality of life,” said Theodore Johnson, MD, PhD.

three men stand in a science lab

MCG faculty researchers named Regents’ Entrepreneurs for advancing health care

The University System of Georgia Board of Regents recently approved David C. Hess, MD, David Munn, MD, and Babak Baban, PhD, as the first three Âé¶ą´«Ă˝Ół»­ faculty researchers to be named Regents’ Entrepreneurs for their success in translating research into a commercial setting to improve patient care.

Man poses for photo in hallway

Novel treatment regimen appears well tolerated, beneficial to children with relapsed brain tumors

The first in-human study of a new immunotherapy that blocks a natural enzyme that tumors commandeer for their protection was well tolerated by children with relapsed brain tumors and enabled many to have unexpected months of a more normal life, researchers say.

Pediatric Immunotherapy Program in The News